ArticleDrug design, development and therapy2019

Codelivery of GRP78 siRNA and docetaxel via RGD-PEG-DSPE/DOPA/CaP nanoparticles for the treatment of castration-resistant prostate cancer.

Xiangyu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.